Clinical Trials Managed in “The Cloud?”
The fundamental concept of cloud computing dates back to the 1960s, when…
Panel on Critical Sales and Distribution Considerations for the Buyer, Investor and Seller
For many emerging healthcare and life science companies, one of their largest…
Neostem’s Suzhou Eyre receives Chinese Regulatory Approval For 6th Production Line
NeoStem (AMEX:NBS) announced Monday that its subsidiary, Suzhou Eyre Pharmaceuticals, has received…
Navigating the Perilous Road: A Special Panel On Regulatory and Reimbursement Issues
The US market represents huge profit potential for an innovative company, but…
June 23-24 OneMedForum New York
OneMedPlace Trans-Atlantic Conference on June 23rd-24th is a gathering of fast growing,…
Rib-X Pharmaceuticals’ Nobel Prize Winning Platform Combats Serious Infections
Rib-X Pharmaceuticals is developing broad spectrum antibiotics with superior coverage, safety and…
Small Bone Innovations Addresses Unmet Needs in Joint Replacement
Small Bone Innovations (SBI) is a specialty medical devices company that has…
OXiGENE Releases Promising Phase Two Data For Lung Cancer Drug
OXiGENE (NASDAQ:OXGN) shares rose in pre-market trading on Monday as it announced…
Phytoceuticals Heals Wounds Through An Easy To Use Spray
Phytoceuticals is developing technology for wound care management through a combination of…
InSite Vision Is Developing Treatment For Common Eye Disease Blepharitis, For Which There Is Currently No Approved Treatment
InSite Vision Inc. (OTCBB:INSV) has reached an agreement with the U.S. InSite…